Folinic acid administration following MTX as prophylaxis for GVHD-Reference-Cited by-同舟云学术

Folinic acid administration following MTX as prophylaxis for GVHD

Published:2009-02-09 Issue:4 Volume:44 Page:257-257
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Gratwohl A

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt20094.pdf

Reference3 articles.

1. Bhurani D, Schifter M, Kerridge I . Folinic acid administration following MTX as prophylaxis for GVHD in allogeneic HSCT centres in Australia and New Zealand. Bone Marrow Transplant 2008; 42: 547–550.

2. Gratwohl AA, Bull MI, Graw Jr RG, Norton L, Knutsen T . Methotrexate and citrovorum factor after histoincompatible allogeneic bone marrow transplants in dogs. Acta Haematol 1978; 60: 233–242.

3. Gratwohl A, Deisseroth A . Suppression of humoral immune response with methotrexate and citroforum factor. In: International Society of Chemotherapy (eds). Current Chemotherapy. American Society for Microbiology, 1978, pp 1262–1263.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Echinochrome A Promotes Ex Vivo Expansion of Peripheral Blood-Derived CD34+ Cells, Potentially through Downregulation of ROS Production and Activation of the Src-Lyn-p110δ Pathway;Marine Drugs;2019-09-09

2. Glutamine and its use in selected oncology settings;South African Journal of Clinical Nutrition;2017-10-02

3. Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice;Bone Marrow Transplantation;2013-07-29

4. Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD;Bone Marrow Transplantation;2011-03-21